Zoetis Inc. (ZTS) financial statements and ratios from SEC XBRL: revenue $9.47B (TTM), net margin 28.2%, revenue growth 1.9% YoY, P/E 11.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $9.47B |
| Net Margin | 28.2% |
| Revenue Growth (YoY) | 1.9% |
| EPS Growth (YoY) | 0.7% |
| FCF Growth (YoY) | -33.6% |
| P/E Ratio | 11.9 |
| EV / EBITDA | 10.9 |
| Price / Book | 9.73 |
| Price / Sales | 3.31 |
| FCF Yield | 3.3% |
| DCF Value (model) | $95.59 |
| DCF Upside vs Price | 27.3% |
| Altman Z-Score | 4.49 (safe) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
ZTS overview · ZTS earnings · ZTS KPIs · ZTS investor relations · ZTS ownership · ZTS peers · ZTS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.